trazodone has been researched along with Basal Ganglia Diseases in 4 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trazodone is a second-generation atypical antidepressant exercising selective inhibitory action on the transport of serotonin." | 1.42 | Trazodone in the elderly: risk of extrapyramidal acute events. ( Esperança, S; Oliveira e Silva, A; Pacheco, AP; Sotto Mayor, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sotto Mayor, J | 1 |
| Pacheco, AP | 1 |
| Esperança, S | 1 |
| Oliveira e Silva, A | 1 |
| Papini, M | 1 |
| Martinetti, MG | 1 |
| Pasquinelli, A | 1 |
| Figiel, GS | 1 |
| Krishnan, KR | 1 |
| Breitner, JC | 1 |
| Nemeroff, CB | 1 |
| Albanese, A | 1 |
| Rossi, P | 1 |
| Altavista, MC | 1 |
4 other studies available for trazodone and Basal Ganglia Diseases
| Article | Year |
|---|---|
Trazodone in the elderly: risk of extrapyramidal acute events.
Topics: Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Basal Ganglia Dise | 2015 |
Trazodone symptomatic extrapyramidal disorders of infancy and childhood.
Topics: Basal Ganglia Diseases; Cerebral Palsy; Child; Child, Preschool; Dystonia; Female; Humans; Infant; L | 1982 |
Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions.
Topics: Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Basal Ganglia; Basal Ganglia Diseases | 1989 |
Can trazodone induce parkinsonism?
Topics: Aged; Basal Ganglia Diseases; Female; Humans; Parkinson Disease, Secondary; Trazodone | 1988 |